Base Genomics aims to have a major impact on personalised medicine. We are developing TAPS, a breakthrough technology from the University of Oxford that makes epigenetic analysis of DNA methylation more sensitive, accurate and cheaper than ever before. We aim to transform healthcare by enabling early and precise detection of cancer. Long-term, we expect TAPS to become central to a host of major new healthcare and research applications. *We are hiring* We are looking for talented chemists, enzymologists, protein engineers, NGS specialists, bioinformaticians and software developers at all levels. Check out the available roles at basegenomics.com/join-us